Edonerpic

Edonerpic Uses, Dosage, Side Effects, Food Interaction and all others data.

Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.

Trade Name Edonerpic
Generic Edonerpic
Edonerpic Other Names Edonerpic
Type
Formula C16H21NO2S
Weight Average: 291.41
Monoisotopic: 291.129300094
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Edonerpic
Edonerpic

Uses

Investigated for use/treatment in alzheimer's disease.

How Edonerpic works

T-817MA has neuroprotective properties. Toyama Chemical has demonstrated that T-817MA prevents neurodegeneration induced by Amyloid-b protein. Accumulation of Amyloid-b protein is considered to be central to the pathogenesis of Alzheimer's disease. The neuroprotective properties of T-817MA were also observed in a mutant tau induced Alzheimer's disease model. Besides these neuroprotective properties, T-817MA also promotes neurite outgrowth.

Innovators Monograph

You find simplified version here Edonerpic

*** Taking medicines without doctor's advice can cause long-term problems.
Share